Clinical Practice
The goal of the Clinical Practice SIG is to promote the practice of Hepatology in a community practice setting.
Cholestatic and Autoimmune Liver Diseases
The Cholestatic and Autoimmune Liver Diseases Special Interest Group (SIG) is an international community of investigators and practitioner focusing on preventing diagnosing and treating cholestatic liver diseases, as well as diseases of the biliary tree (cholangiopathies). The SIG also strongly focuses on understanding the pathophysiology and on the genetics of cholestatic and biliary diseases as a way to identify novel therapeutic targets.
Pediatric Autoimmune Liver Disease
Henry C. Lin – 22 May 2022
Assessment of Alcohol and Other Substance Use in Patients With Chronic Liver Disease
- Read more about Assessment of Alcohol and Other Substance Use in Patients With Chronic Liver Disease
Rachel L. Bachrach, Shari S. Rogal – 22 May 2022
Psychiatric Disorders and Their Treatment: Impact of Outcomes in Patients With Chronic Liver Disease
Rachel Holmes, Anahli Patel, Archita P. Desai – 22 May 2022
Treatment of Mental Health in Patients With Chronic Liver Disease
Thomas G. Cotter, Thomas Beresford – 22 May 2022
Clinical Phenotyping and the Application of Precision Medicine in MAFLD
Saad Saffo, Albert Do – 22 May 2022
Donor eligibility criteria and liver graft acceptance criteria during normothermic regional perfusion: A systematic review
Ivo J. Schurink, Fenna E. M. Leemkolk, Constantino Fondevila, Riccardo De Carlis, Eric Savier, Gabriel C. Oniscu, Volkert A. L. Huurman, Jeroen Jonge – 22 May 2022 – Acceptance of liver grafts from donations after circulatory death (DCD) largely remains a “black box,” particularly due to the unpredictability of the agonal phase. Abdominal normothermic regional perfusion (aNRP) can reverse ischemic injury early during the procurement procedure, and it simultaneously enables graft viability testing to unravel this black box.
Pediatric Autoimmune Liver Disease
Henry C. Lin – 22 May 2022
PAR2 promotes impaired glucose uptake and insulin resistance in NAFLD through GLUT2 and Akt interference
Andrew M. Shearer, Yanling Wang, Elizabeth K. Fletcher, Rajashree Rana, Emily S. Michael, Nga Nguyen, Manal F. Abdelmalek, Lidija Covic, Athan Kuliopulos – 22 May 2022